DePuy Synthes unveils TriLEAP Lower Extremity Anatomic Plating System Ruchika Sharma11 Aug 2024 1:30 PM ISTWest Chester: Johnson & Johnson MedTech has announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has launched its...
JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Johnson & Johnson beat estimates for Q2 profit, revenue Ruchika Sharma18 July 2024 4:53 PM ISTLondon:Johnson & Johnson exceeded expectations in its second-quarter profit and revenue announced on Wednesday, propelled by robust sales of its...
JnJ strengthens atopic dermatitis pipeline with acquisition of Yellow Jersey Therapeutics Ruchika Sharma14 July 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Yellow Jersey, a demerged...
COVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent Ruchika Sharma9 July 2024 5:49 PM ISTEmergent BioSolutions has said that Johnson & Johnson has agreed to settle claims arising from the termination of the manufacturing deal for the...
JnJ completes acquisition of Proteologix Ruchika Sharma23 Jun 2024 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...
JnJ submits application to USFDA for Subcutaneous amivantamab for patients with EGFR-mutated non-small cell lung cancer Ruchika Sharma19 Jun 2024 3:56 PM ISTRaratin: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration...
Johnson and Johnson reaches USD 700 million talc settlement with US states Ruchika Sharma12 Jun 2024 11:30 AM ISTNew York: Johnson & Johnson has reached a settlement of $700 million to resolve an investigation by 42 U.S. states and Washington, D.C....
JnJ submits application to USFDA for expansion of Pediatric indication for HIV-1 Therapy Prezcobix Ruchika Sharma5 Jun 2024 1:00 PM ISTTitusville: Johnson & Johnson has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug...
Johnson & Johnson concludes acquisition of Shockwave Medical Ruchika Sharma2 Jun 2024 3:31 PM ISTNew Brunswick: Johnson & Johnson has announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson &...
Johnson & Johnson Executive Vice President William N Hait to retire Ruchika Sharma1 Jun 2024 2:15 PM ISTNew Brunswick: Johnson & Johnson has announced that William N. (Bill) Hait, M.D., Ph.D., will retire from his position as Executive Vice...
JnJ to buy rights to Numab Therapeutics Clinical-Stage Bispecific Antibody NM26 Ruchika Sharma29 May 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement with Numab Therapeutics, a clinical-stage...
